This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Colestilan chloride
- DrugBank Accession Number
- DB11634
- Background
Colestilan is an ingredient in the EMA-withdrawn product BindRen.
- Type
- Small Molecule
- Groups
- Approved, Investigational, Withdrawn
- Synonyms
- Colestilan
- Colestilan chloride
- External IDs
- MCI-196
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Hyperphosphataemia •••••••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Bindren Tablet, film coated 1 g Oral Mitsubishi Pharma Europe Ltd 2016-09-08 2015-04-01 EU 
Bindren Tablet, film coated 1 g Oral Mitsubishi Pharma Europe Ltd 2016-09-08 2015-04-01 EU Bindren Granule 3 g Oral Mitsubishi Pharma Europe Ltd 2016-09-08 2015-04-01 EU Bindren Granule 2 g Oral Mitsubishi Pharma Europe Ltd 2016-09-08 2015-04-01 EU Bindren Tablet, film coated 1 g Oral Mitsubishi Pharma Europe Ltd 2016-09-08 2015-04-01 EU
Categories
- ATC Codes
- V03AE06 — Colestilan
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- VSI302RYSR
- CAS number
- 95522-45-5
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- EMA Summary of Product Characteristics: BindRen (colestilan) for oral use [Link]
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Completed Treatment Chronic Kidney Disease (CKD) 1 3 Completed Treatment Chronic Kidney Disease (CKD) / Dialysis therapy / Dyslipidemia / Hyperphosphataemia 1 3 Completed Treatment Chronic Kidney Disease (CKD) / Dialysis therapy / Hyperphosphataemia 3 3 Completed Treatment Chronic Kidney Disease (CKD) / Hyperphosphataemia 1 3 Terminated Treatment Chronic Kidney Disease (CKD) / Dialysis therapy / Hyperphosphataemia 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Granule Oral 2 G Granule Oral 3 G Tablet, film coated Oral 1 G - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at October 17, 2016 21:27 / Updated at February 21, 2021 18:53